Prevalence and genotype distribution of pneumocystis jirovecii in cuban infants and toddlers with whooping cough

Journal of Clinical Microbiology

Volumn 52, Issue 1, 2014, Pages 45-51

  Monroy Vaca, Ernesto X ^a   De Armas, Yaxsier ^a   Illnait Zaragozí, María T ^a   ToraÑo, Gilda ^a   Diaz, Raúl ^a   Vega, Dania ^b   Alvarez Lam, Ileana ^c   Calderón, Enrique J ^d   Stensvolde, Christen R ^e  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b Juan Manuel Marquez Pediatric Hospital   (Cuba)

^c HOSPITAL PEDIÁTRICO DOCENTE WILLIAM SOLER   (Cuba)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CHILD; CONTROLLED STUDY; CUBA; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERTUSSIS; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROAT CULTURE;

CHILD; CHILD, PRESCHOOL; CUBA; DNA, FUNGAL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR SEQUENCE DATA; NASOPHARYNX; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECII; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; WHOOPING COUGH;

EID: 84891548336     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02381-13     Document Type: Article

References (51)

1. Calderón EJ, de Armas Y, Panizo MM, Wissmann G. 2013. Pneumocystis jirovecii pneumonia in Latin America: A public health problem? Expert Rev. Anti Infect. Ther. 11:565-570. http://dx.doi.org/10.1586/eri.13.41.
2. Contini C, Villa MP, Romani R, Merolla R, Delia S, Ronchetti R. 1998. Detection of Pneumocystis carinii among children with chronic respiratory disorders in the absence of HIV infection and immunodeficiency. J. Med. Microbiol. 47:329-333.
3. Morris A, Norris KA. 2012. Colonization by Pneumocystis jirovecii and its role in disease. Clin. Microbiol. Rev. 25:297-317. http://dx.doi.org/10.1128/ CMR.00013-12.
4. Peterson JC, Cushion MT. 2005. Pneumocystis: Not just pneumonia. Curr. Opin. Microbiol. 8:393-398. http://dx.doi.org/10.1016/j.mib.2005.06.010.
5. Krajicek BJ, Thomas CF, Jr, Limper AH. 2009. Pneumocystis pneumonia: Current concepts in pathogenesis, diagnosis, and treatment. Clin. Chest Med. 30:265-278. http://dx.doi.org/10.1016/j.ccm.2009.02.005.
6. van den Bergh MR, Biesbroek G, Rossen JW, de Steenhuijsen Piters WA, Bosch AA, van Gils EJ, Wang X, Boonacker CW, Veenhoven RH, Bruin JP, Bogaert D, Sanders EA. 2012. Associations between pathogens in the upper respiratory tract of young children: Interplay between viruses and bacteria. PLoS One 7:e47711. http://dx.doi.org/10.1371/journal.pone .0047711.
7. Esteves F, Gaspar J, Tavares A, Moser I, Antunes F, Mansinho K, Matos O. 2010. Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients. Infect. Genet. Evol. 10:192-199. http://dx.doi.org/10.1016/j.meegid.2009.12.007.
8. Esteves F, Gaspar J, de Sousa B, Antunes F, Mansinho K, Matos O. 2011. Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii pneumonia: Development of a multiplex PCRsingle-base-extension methodology. J. Clin. Microbiol. 49:1810-1815. http://dx.doi.org/10.1128/JCM. 02303-10.
9. Matos O, Esteves F. 2010. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. Parasite 17:219-232. http://dx.doi.org/10.1051/parasite/2010173219.
10. Nevez G, Totet A, Pautard JC, Raccurt C. 2001. Pneumocystis carinii detection using nested-PCR in nasopharyngeal aspirates of immunocompetent infants with bronchiolitis. J. Eukaryot. Microbiol. 48(Suppl 1): 122S-123S. http://dx.doi.org/10.1111/j.1550-7408.2001.tb00479.x.
11. Vargas SL, Ponce CA, Gallo M, Pérez F, Astorga JF, Bustamante R, Chabé M, Durand-Joly I, Iturra P, Miller RF, Aliouat EM, Dei-Cas ME. 2013. Near-universal prevalence of Pneumocystis and associated increase in mucus in the lungs of infants with sudden unexpected death. Clin. Infect. Dis. 56:171-179. http://dx.doi.org/10.1093/cid/cis870.
12. World Health Organization. 2003. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Publication WHO/V&B/03.01. World Health Organization, Geneva, Switzerland.
13. Dini L, Plessis M, Frean J, Fernandez V. 2010. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa. J. Clin. Microbiol. 48:2016-2021. http://dx.doi.org/10.1128/JCM.02004-09.
14. Applied Biosystems. 2003. Creating standard curves with genomic DNA or plasmid DNA templates for use in quantitative PCR. Applied Biosystems, Foster City, CA.
15. Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaff M, Shipley G, Vandesompele J, Wittwer C. 2009. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55:611-622. http://dx.doi.org/10.1373/clinchem.2008. 112797.
16. Ghossein RA, Ross DG, Salomon RN, Rabson AR. 1994. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am. J. Clin. Pathol. 101:733-737.
17. Wakefield AE. 1996. DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J. Clin. Microbiol. 34:1754-1759.
18. Sinclair K, Wakefield AE, Banerji S, Hopkin JM. 1991. Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct. Mol. Biochem. Parasitol. 45:183-184.
19. Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, Roberts JM, Hightower AW, Bens MS, Freeman AR, Lee S, Stringer JR, Duchin JS, del Rio C, Rimland D, Baughman RP, Levy DA, Dietz VJ, Simon P, Navin TR. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: Implications for transmission. Emerg. Infect. Dis. 6:265-272. http://dx.doi.org/10.1093/infdis/175.2.482.
20. Lane BR, Ast JC, Hossler PA, Mindell DP, Bartlett MS, Smith JW, Meshnick SR. 1997. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J. Infect. Dis. 175:482-485.
21. Helweg-Larsen J, Eugen-Olsen J, Lundgren B. 2000. Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restrictionfragmentlengthpolymorphism.Scand.J. Infect. Dis. 32:481-483.http:// dx.doi.org/10.1080/003655400458730.
22. Totet A, Latouche S, Duwat H, Magois E, Lacube P, Pautard JC, Schmit JL, Jounieaux V, Roux P, Raccurt C, Nevez G. 2003. Multilocus genotyping of Pneumocystis jirovecii in patients developing diverse forms of parasitism: Implication for a wide human reservoir for the fungus. J. Eukaryot. Microbiol. 50:670-671. http://dx.doi.org/10.1368/1066-5234(2003)050[0670:MGOPJI]2.0.CO;2.
23. Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, Cumsille F, Gigliotti F. 2001. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32:855-861. http://dx.doi.org/10.1086/319340.
24. Vargas SL, Ponce CA, Hughes WT, Wakefield AE, Weitz JC, Donoso S, Ulloa AV, Madrid P, Gould S, Latorre JJ, Avila R, Benveniste S, Gallo M, Belletti J, Lopez R. 1999. Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin. Infect. Dis. 29:1489-1493.
25. Beard CB, Fox MR, Lawrence GG, Guarner J, Hanzlick RL, Huang L, del Rio C, Rimland D, Duchin JS, Colley DG. 2005. Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological implications. J. Infect. Dis. 192: 1815-1818. http://dx.doi.org/10.1086/497381.
26. Gołab E, Rozej-Bielicka W, Pancer K. 2011. Evaluation of the frequency of Pneumocystis jirovecii occurrence in a group of children hospitalized for acute respiratory infections. Wiad. Parazytol. 57:93-96.
27. Wakefield AD, Fritscher CC, Malin AS, Gwanzura L, Hughes WT, Miller RF. 1994. Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences. J. Clin. Microbiol. 32:2959-2961.
28. de Armas Y, Friaza V, Capó V, Durand-Joly I, Govín A, de la Horra C, Dei-Cas E, Calderón EJ. 2012. Low genetic diversity of Pneumocystis jirovecii among Cuban population based on two-locus mitochondrial typing. Med. Mycol. 50:417-420. http://dx.doi.org/10.3109/13693786.2011 .607474.
29. Montes-Cano MA, de la Horra C, Dapena FJ, Mateos I, Friaza V, Respaldiza N, Muñoz-Lobato F, Medrano FJ, Calderon EJ, Varela JM. 2007. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients. Clin. Microbiol. Infect. 13:1008-1011. http://dx.doi.org/10.1111/j. 1469-0691.2007.01789.x.
30. Jarboui MA, Mseddi F, Sellami H, Sellami A, Makni F, Ayadi A. 2013. Genetic diversity of Pneumocystis jirovecii strains based on sequence variation of different DNA region. Med. Mycol. 51:561-567. http://dx.doi.org/10.3109/ 13693786.2012.744879.
31. Dimonte S, Berrilli F, D'Orazi C, D'Alfonso R, Placco F, Bordi E, Perno CF, Di Cave D. 2013. Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy. Infect. Genet. Evol. 14:68-72. http://dx.doi.org/10.1016/j.meegid.2012. 11.012.
32. Gupta R, Mirdha BR, Guleria R, Kumar-Agarwal SK, Samantaray JC, Kumar L, Kabra SK, Luthra K, Sreenivas V, Iyer VK. 2011. Genotypic variation of Pneumocystis jirovecii isolates in India based on sequence diversity at mitochondrial large subunit rRNA. Int. J. Med. Microbiol. 301: 267-272. http://dx.doi.org/10.1016/j.ijmm.2010.05.001.
33. Miller RF, Lindley AR, Copas A, Ambrose HE, Davies RJ, Wakefield AE. 2005. Genotypic variation in Pneumocystis jirovecii isolates in Britain. Thorax 60:679-682. http://dx.doi.org/10.1136/thx.2004.039818.
34. Montes-Cano MA, de la Horra C, Martín-Juan J, Varela JM, Torronteras R, Respaldiza N, Medrano FJ, Calderón EJ. 2004. Pneumocystis jiroveci genotypes in the Spanish population. Clin. Infect. Dis. 39:123-128. http://dx.doi.org/10.1086/421778.
35. Esteves F, Montes-Cano MA, de la Horra C, Costa MC, Calderón EJ, Antunes F, Matos O. 2008. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin. Microbiol. Infect. 14: 356-362. http://dx.doi.org/10.1111/j.1469-0691.2007.01944.x.
36. van Hal SJ, Gilgado F, Doyle T, Barratt J, Stark D, Meyer W, Harkness J. 2009. Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J. Clin. Microbiol. 47:1818-1823. http://dx.doi.org/10.1128/JCM.02102-08.
37. Hauser PM, Nahimana A, Taffe P, Weber R, Francioli P, Bille J, Rabodonirina M. 2010. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin. Infect. Dis. 51:e28-e33. http://dx.doi.org/10.1086/655145.
38. Hauser PM, Francioli P, Bille J, Telenti A, Blanc DS. 1997. Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J. Clin. Microbiol. 35:3086-3091.
39. Miller RF, Lindley AR, Ambrose HE, Malin AS, Wakefield AE. 2003. Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom. Antimicrob. Agents Chemother. 47:3979-3981. http://dx.doi.org/10.1128/AAC.47.12.3979-3981.2003.
40. Phipps LM, Chen SC, Kable K, Halliday CL, Firacative C, Meyer W, Wong G, Nankivell BJ. 2011. Nosocomial Pneumocystis jirovecii pneumonia: Lessons from a cluster in kidney transplant recipients. Transplantation 92:1327-1334. http://dx.doi.org/10.1097/TP.0b013e3182384b57.
41. Huang L, Beard CB, Creasman J, Levy D, Duchin JS, Lee S, Pieniazek N, Carter JL, del Rio C, Rimland D, Navin TR. 2000. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis. 182:1192-1198. http://dx.doi.org/10.1086/315824.
42. Ma L, Borio L, Masur H, Kovacs JA. 1999. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis. 180:1969-1978.
43. Armstrong W, Meshnick S, Kazanjian P. 2000. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect. 2:61-67. http://dx.doi.org/10.1016/ S1286-4579(00)00284-7.
44. Nahimana A, Rabodonirina M, Zanetti G, Meneau I, Francioli P, Bille J, Hauser PM. 2003. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and-negative patients. J. Infect. Dis. 188:1017-1023. http://dx.doi.org/10.1086/378239.
45. Kazanjian P, Armstrong W, Hossler PA, Burman W, Richardson J, Lee CH, Crane L, Katz J, Meshnick SR. 2000. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis. 182:551-557. http://dx.doi.org/10.1086/315719.
46. Rabodonirina M, Nahimana A, Weber R, Francioli P, Bille J, Hauser PM. 2006. Geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations within Western Europe. J. Eukaryot. Microbiol. 53(Suppl 1):S112-S113. http://dx.doi.org/10.1111/j .1550-7408.2006.00194.x.
47. Navin TR, Beard CB, Huang L, del Rio C, Lee S, Pieniazek NJ, Carter JL, Le T, Hightower A, Rimland D. 2001. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: A prospective study. Lancet 358:545-549. http://dx.doi.org/10.1016/ S0140-6736(01)05705-1.
48. Yoon C, Subramanian A, Chi A, Crothers K, Meshnick SR, Taylor SM, Beard CB, Jarlsberg LG, Lawrence GG, Avery M, Swartzman A, Fong S, Roth B, Huang L. 2013. Dihydropteroate synthase mutations in Pneumocystis pneumonia: Impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort. Med. Mycol. 51:568-575. http://dx.doi.org/10.3109/13693786. 2013.770604.
49. Kirkwood BR, Gove S, Rogers S, Lob-Levyt J, Arthur P, Campbell H. 1995. Potential interventions for the prevention of childhood pneumonia in developing countries: A systematic review. Bull. World Health Organ. 73:793-798.
50. Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, Quintero N, Flores M, Shor-Posner G. 2005. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int. J. Infect. Dis. 9:208-217. http://dx.doi.org/10.1016/j.ijid .2004.07.010.
51. Ortíz PL, Pérez A, Rivero A, León N, Díaz M, Pérez A. 2008. Assessment of human health vulnerability to climate variability and change in Cuba. MEDICC Rev. 10:31-48. http://www.medicc.org/ mediccreview/index .php?issue-4&id-36&a-vahtml.